JP2006503056A5 - - Google Patents

Download PDF

Info

Publication number
JP2006503056A5
JP2006503056A5 JP2004537671A JP2004537671A JP2006503056A5 JP 2006503056 A5 JP2006503056 A5 JP 2006503056A5 JP 2004537671 A JP2004537671 A JP 2004537671A JP 2004537671 A JP2004537671 A JP 2004537671A JP 2006503056 A5 JP2006503056 A5 JP 2006503056A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
halogens
och
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004537671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006503056A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/025860 external-priority patent/WO2004026837A2/en
Publication of JP2006503056A publication Critical patent/JP2006503056A/ja
Publication of JP2006503056A5 publication Critical patent/JP2006503056A5/ja
Pending legal-status Critical Current

Links

JP2004537671A 2002-09-18 2003-09-12 ヒスタミンh3受容体アンタゴニスト、その製造および治療用使用 Pending JP2006503056A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41162502P 2002-09-18 2002-09-18
PCT/US2003/025860 WO2004026837A2 (en) 2002-09-18 2003-09-12 Histamine h3 receptor antagonists, preparaton and therapeutic uses

Publications (2)

Publication Number Publication Date
JP2006503056A JP2006503056A (ja) 2006-01-26
JP2006503056A5 true JP2006503056A5 (enExample) 2006-10-19

Family

ID=32030698

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004537671A Pending JP2006503056A (ja) 2002-09-18 2003-09-12 ヒスタミンh3受容体アンタゴニスト、その製造および治療用使用

Country Status (5)

Country Link
US (1) US20060167046A1 (enExample)
EP (1) EP1585731A2 (enExample)
JP (1) JP2006503056A (enExample)
AU (1) AU2003268117A1 (enExample)
WO (1) WO2004026837A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR048134A1 (es) * 2003-12-15 2006-04-05 Lundbeck & Co As H La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial
US20060069087A1 (en) * 2004-09-27 2006-03-30 Pfizer Inc Histamine-3 receptor antagonists
CA2615007A1 (en) 2005-07-13 2007-01-18 F. Hoffmann-La Roche Ag Benzimidazole derivatives as 5-ht6,5-ht24
ATE485294T1 (de) * 2005-11-18 2010-11-15 Hoffmann La Roche Azaindol-2-carboxamid-derivate
DE602006010433D1 (de) * 2005-12-09 2009-12-24 Hoffmann La Roche Für die behandlung von obesitas geeignete tricyclische amidderivate
CA2646023A1 (en) 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
EP2017263A4 (en) 2006-05-09 2011-11-30 Daiichi Sankyo Co Ltd Heteroarylamide derivative of a lower carboxylic acid
KR20090127307A (ko) 2007-03-01 2009-12-10 얀센 파마슈티카 엔.브이. 히스타민 h3 수용체 조절제로서의 테트라하이드로이소퀴놀린 화합물
WO2008126886A1 (ja) * 2007-04-12 2008-10-23 Taisho Pharmaceutical Co., Ltd. インドール又はインドリン誘導体
TW201039822A (en) * 2009-02-06 2010-11-16 Taisho Pharmaceutical Co Ltd Dihydroquinolinone derivatives
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5310986B2 (enExample) * 1974-02-05 1978-04-18
JPS5310989B2 (enExample) * 1974-04-25 1978-04-18
JPS533534A (en) * 1976-06-30 1978-01-13 Otsuka Pharmaceut Co Ltd Local anesthetics
JPS5780322A (en) * 1980-11-05 1982-05-19 Otsuka Pharmaceut Co Ltd Cardiotonic agent
JPS63290821A (ja) * 1987-05-25 1988-11-28 Otsuka Pharmaceut Co Ltd 抗不整脈剤
AU2001244088A1 (en) * 2000-03-17 2001-09-24 Boehringer Ingelheim International G.M.B.H Condensed imidazoles as histamine h3 receptor ligands
GB0019950D0 (en) * 2000-08-12 2000-09-27 Smithkline Beecham Plc Compounds
ES2233708T3 (es) * 2000-09-20 2005-06-16 Schering Corporation Imidazoles sustituidos como agonistas o antagonistas duales de la histamina h1 y la h3.
TW593278B (en) * 2001-01-23 2004-06-21 Wyeth Corp 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands

Similar Documents

Publication Publication Date Title
JP2004516314A5 (enExample)
JP2005523922A5 (enExample)
JP2006515858A5 (enExample)
JP2009536660A5 (enExample)
JP2009507896A5 (enExample)
JP2010501478A5 (enExample)
JP2005526144A5 (enExample)
JP2010539110A5 (enExample)
JP2009529540A5 (enExample)
JP2010511721A5 (enExample)
JP2006524222A5 (enExample)
JP2005505618A5 (enExample)
JP2005511547A5 (enExample)
JP2013512277A5 (enExample)
JP2006503056A5 (enExample)
JP2007519618A5 (enExample)
JP2005530811A5 (enExample)
JP2009518365A5 (enExample)
JP2003503449A5 (enExample)
JP2004529145A5 (enExample)
JP2004525183A5 (enExample)
JP2004523478A5 (enExample)
JP2013513607A5 (enExample)
JP2005526773A5 (enExample)
JP2006516626A5 (enExample)